RSNA15: Study Shows Link Between Early-Stage Brain and Heart Disease
"We know that myocardial infarction, heart failure and atrial fibrillation are associated with an increased risk of stroke and dementia," says Hazel Zonneveld, MD, MSc, from the Department of Epidemiology and Radiology at Erasmus University Medical Center in Rotterdam. "Our study investigates whether the heart-brain link is present at an earlier stage of disease."
Dr. Zonneveld and colleagues analysed data from 2,432 participants in the Rotterdam Study (57.4 percent women, mean age 56.6 years), a prospective, population-based study designed to investigate chronic diseases in Rotterdam's ageing population. Participants with overt heart disease, dementia and brain infarcts (strokes) were excluded from the analysis.
Participants underwent brain MRI, which included the use of an advanced technique called diffusion tensor imaging (DTI), and blood testing to measure levels of N-terminal pro b-type natriuretic peptide (NT-proBNP) — a marker of heart disease.
"NT-proBNP is released into the bloodstream in response to myocardial wall stress," Dr. Zonneveld explained. "Studies have demonstrated that NT-proBNP provides information on cardiac dysfunction even in the absence of overt heart disease."
Dr. Zonneveld's team evaluated the brain MRI results for markers of early brain disease, including a loss of brain volume, microstructural changes and white matter lesions, which indicate areas of cells that have been damaged by injury or disease.
The results of DTI showed that participants with higher NT-proBNP levels had worse microstructural organization within the white matter. Further analysis revealed that higher NT-proBNP levels were also associated with smaller total brain volume and larger white matter lesion volume. The brain volume loss was mainly in the grey matter, said Dr. Zonneveld.
The study is the first to demonstrate an association between NT-proBNP and the microstructure of the brain, she added.
Editorial Project Director, HealthManagement.org
Source and image credit: RSNA
Published on : Thu, 3 Dec 2015
The best patient care is your ultimate goal. To achieve this requires confident diagnosis even with daily increases in patient throughput. Built on the foundation of Mindray’s continuous customer insights into clinical needs and the inheritance from...
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
Image accuracy in hand The first wireless, handheld breast ultrasound with exceptional breast image quality. Delivers accurate diagnostic images at the point of care. Ideal for quick diagnostic looks, visual confirmations, interventional procedures,...
A better 3D™ breast screening experience – for everyone. The new 3Dimensions™ system is designed to provide higher quality 3D™ images for radiologists, a more comfortable mammography experience for patients and enhanced workflow for technologists....
A breakthrough in biopsy efficiency The Brevera system streamlines the entire breast biopsy process from start to finish – with real-time imaging for instant verification and automated post-biopsy specimen handling. This has the potential to...